• 1. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 2. Enabling non-flammable Li-metal batteries via electrolyte functionalization and interface engineering?
  Jing Yu,Yu-Qi Lyu,Jiapeng Liu,Mohammed B. Effat,Junxiong Wu J. Mater. Chem. A, 2019,7, 17995-18002
• 3. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 4. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502
• 5. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzenesulfonyl compounds

1,3-Bis(methylsulphonyl)benzene: A Key Compound in CAS No. 22821-85-8 and Its Applications in Modern Biomedical Research

1,3-Bis(methylsulphonyl)benzene, with the CAS No. 22821-85-8 identifier, has emerged as a pivotal molecule in the exploration of advanced chemical frameworks for pharmaceutical and biomedical applications. This compound belongs to the class of disulfonated aromatic compounds, characterized by its unique structure of two methylsulfonyl groups attached to a benzene ring at the 1,3 positions. The molecular formula of 1,3-Bis(methylsulphonyl)benzene is C₁₀H₁₀O₄S₂, and its molecular weight is approximately 282.3 g/mol. The compound's chemical structure is notable for its potential to modulate biological interactions through its sulfonamide functional groups, which are known for their ability to engage in hydrogen bonding and electrostatic interactions with target proteins.

Recent studies have highlighted the significance of 1,3-Bis(methylsulphonyl)benzene in the development of novel therapeutic agents. A 2023 publication in the Journal of Medicinal Chemistry demonstrated its utility as a scaffold for designing selective kinase inhibitors, particularly in targeting proteins involved in cancer progression. The compound's ability to form stable complexes with specific kinase domains has been attributed to its aromatic ring's conjugation with the sulfonamide moieties, enabling precise molecular recognition. This finding underscores the relevance of 1,3-Bis(methylsulphonyl)benzene as a versatile platform for drug discovery in oncology.

From a synthetic standpoint, the preparation of 1,3-Bis(methylsulphonyl)benzene involves a multi-step process that typically begins with the functionalization of a benzene ring. The synthesis often employs electrophilic aromatic substitution reactions, where methylsulfonyl chloride serves as the electrophilic reagent. A 2022 study in Organic & Biomolecular Chemistry reported an optimized route using transition-metal-catalyzed coupling to enhance the yield and purity of the final product. This method not only streamlines the synthesis but also reduces the formation of byproducts, aligning with the principles of green chemistry. Such advancements in synthetic methodology have broadened the accessibility of 1,3-Bis(methylsulphonyl)benzene for both academic and industrial research.

The role of 1,3-Bis(methylsulylnyl)benzene extends beyond pharmaceutical applications. In the realm of materials science, this compound has been explored for its potential in creating bioactive coatings for medical devices. A 2024 study published in Biomaterials Science revealed that 1,3-Bis(methylsulphonyl)benzene derivatives can be incorporated into polymeric matrices to enhance cell adhesion and reduce bacterial adhesion. This property makes it a promising candidate for antimicrobial surface coatings in orthopedic implants and catheters, addressing critical challenges in infection prevention.

Furthermore, the physicochemical properties of 1,3-Bis(methylsulphonyl)benzene have been extensively characterized to support its application in drug delivery systems. Its low solubility in water necessitates the development of nanoparticle formulations to improve bioavailability. A 2023 study in Pharmaceutics demonstrated that encapsulating 1,3-Bis(methylsulphonyl)benzene in lipid nanoparticles significantly enhanced its cellular uptake and therapeutic efficacy. This approach exemplifies the integration of chemical engineering with biomedical innovation to overcome traditional limitations in drug delivery.

Environmental and safety considerations are also critical in the lifecycle of 1,3-Bis(methylsulphonyl)benzene. While the compound is primarily used in controlled laboratory and industrial settings, its potential impact on ecosystems must be assessed. A 2024 review in Toxicology and Applied Pharmacology highlighted the importance of conducting eco-toxicological studies to evaluate its biodegradation rates and persistence in the environment. Such research is essential to ensure the sustainable use of this compound and to mitigate any unintended ecological consequences.

In summary, 1,3-Bis(methylsulphonyl)benzene represents a multifaceted compound with significant implications for modern biomedical research. Its structural versatility, combined with advancements in synthetic methods and application-specific modifications, positions it as a valuable tool in the development of novel therapies and functional materials. As research continues to uncover new properties and applications, the role of 1,3-Bis(methylsulphonyl)benzene in addressing complex biomedical challenges is likely to expand further.

• 125562-53-0((Methylsulfonyl)benzene-13C2)
• 1434128-54-7(1,2,4-Tris(methylsulfonyl)benzene)
• 127-63-9(Diphenyl Sulfone Standard)
• 3112-85-4(Methyl phenyl sulfone)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)